Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares, at a price of approximately HK$72.88 per share.
After the increase, the latest number of shares held is 15.096 million shares, and the latest shareholding ratio is 5.05%.
According to the latest data from the Hong Kong Stock Exchange, on July 30, Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares at a price of HKD 72.8753 per share, for a total amount of approximately HKD 14.8301 million. After the increase, the total number of shares held is 15.096 million, with the latest shareholding ratio at 5.05%.
Related Articles
TOP EDUCATION (01752): Noted potential data security incident, currently has not caused any significant disruption to the Group's operations.
Greentown China (03900) reported total contract sales of approximately 107 billion yuan over the first seven months, representing a year-on-year decrease of 21.78%.
EACON (07687) green shoe mechanism implemented: partial exercise of the overallotment option, multiple brokerages intensively covering with initial buy ratings.
TOP EDUCATION (01752): Noted potential data security incident, currently has not caused any significant disruption to the Group's operations.
Greentown China (03900) reported total contract sales of approximately 107 billion yuan over the first seven months, representing a year-on-year decrease of 21.78%.
EACON (07687) green shoe mechanism implemented: partial exercise of the overallotment option, multiple brokerages intensively covering with initial buy ratings.
RECOMMEND
